2 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow 2141-V11: new trials by email Literature Review of 2141-V11 trials Research Report on 2141-V11
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients D2C7-IT, 2141-V11 - Newly Diagnosed MGMT Unmethylated Glioblastoma | Phase 1 / Phase 2 | Recruiting | Darell Bigner | 50 | 2023-09-06 | 2026-10-16 |
| Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma D2C7-IT, 2141-V11 - Glioma, Malignant | Phase 1 | Recruiting | Darell Bigner | 90 | 2021-07-09 | 2026-06-04 |
Glioblastoma (2) · Glioma (1)
Darell Bigner (2)
United States (2)
Annick Desjardins, MD,FRCPC (1) · Daniel Landi, MD (1)